Spartan Bioscience Announces 6,000-Patient Study of Personalized Medicine for Cardiac Stents
Landmark clinical trial begins for rapid DNA testing and personalized anti-blood clotting drugs.Ottawa, Ontario (PRWEB) December 20, 2012 Spartan Bioscience today announced the start of a 5,945-patient study of personalized medicine for cardiac stent patients. The study is sponsored by the Center for Individualized Medicine at Mayo Clinic and is entitled “Tailored Antiplatelet Initiation to Lessen Outcomes due to Clopidogrel Resistance after Percutaneous Coronary Intervention (TAILOR-PCI). ...
Source: news.yahoo.com
No comments:
Post a Comment